Evidence map›Paper›PMID 41250819›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Single-Position Peptide Clustering for Peptidomics Reveals Novel Disease Biomarkers and Dysregulated Proteolytic Characteristics.

Na Li, Yaxin Zhu, Yumeng Yan, Jifeng Wang, Lili Niu, Xiang Ding, Mengmeng Zhang, Zhensheng Xie, Tanxi Cai, Xiaojing Guo and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Na LiLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Yaxin ZhuLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Yumeng YanLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Jifeng WangLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Lili NiuLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Xiang DingLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Mengmeng ZhangLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Zhensheng XieLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Tanxi CaiLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Xiaojing GuoLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Jianming LuoDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Peng AnDepartment of Nutrition and Health, China Agricultural University, Beijing, 100193, China.
Xiangqian GuoHenan Provincial Engineering Center for Tumor Molecular Medicine, Zhongyuan Intelligent Medical Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China.
Fuquan YangLaboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.ORCID https://orcid.org/0000-0002-2841-5342

Funding

National Key Research and Development Program of China 2023YFF0713804
6 · The paper itself

Abstract

Mass spectrometry-based peptidomics provides a comprehensive platform for mapping global proteolytic alterations and identifying disease biomarkers. However, existing analytical frameworks often lack the precision to capture disease-specific signatures. Here, a single-position peptide clustering strategy is introduced, leveraging the amino acid score (aa-score) method, and applying it to plasma peptidomics in β-thalassemia. By integrating grouped aa-scores with tailored visualization, a clear and interpretable profile of protein degradation is generated from otherwise redundant datasets. Importantly, the use of heavy-labeled peptides or reference samples in targeted quantitative peptidomics enabled, for the first time, the proposal of aa position-based peptide cluster biomarkers. Combined with proteomics and complementary analyses, this strategy revealed disease-specific peptide-protein-protease relationships. Furthermore, the robustness of the aa-score framework is demonstrated by applying an individualized algorithm based on reference samples in an independent cohort study, highlighting its capacity to address missing values and improve overall performance.

Indexed as

beta-ThalassemiaBiomarkersPeptidesProteomicsAlgorithmsHumansMass SpectrometryProteolysisBiomarkersPeptidesamino acid scorebiomarkerpeptide clusterpeptidomicssingle‐position peptide clustering

Identifiers

PMID41250819
PMCPMC12850352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.